Search
Patexia Research
Case number 2017-1455

Endo Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. > Documents

Date Field Doc. No.Description (Pages)
May 6, 2019 15 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [605101] [17-1240, 17-1455, 17-1887] [PBC] [Entered: 05/06/2019 10:54 AM] (2)
Mar 28, 2019 13 OPINION filed for the court by Wallach, Circuit Judge; Clevenger, Circuit Judge and Stoll, Circuit Judge. Precedential Opinion. [596105] [17-1240, 17-1455, 17-1887] [PBC] [Entered: 03/28/2019 09:42 AM] (17)
Mar 28, 2019 14 JUDGMENT filed. REVERSED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [596106] [17-1240, 17-1455, 17-1887] [PBC] [Entered: 03/28/2019 09:43 AM] (2)
Mar 15, 2018 12 Note to file: The following cases are consolidated: 17-1240 (Lead) with 17-1455 and 17-1887 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [505708] [17-1240, 17-1455, 17-1887] [MJL] [Entered: 03/15/2018 04:30 PM] (0)
Apr 12, 2017 10 ORDER consolidating appeals (17-1887 with 17-1094, -1240, -1444, -1455). The revised official caption is reflected in the order. Endo Pharmaceuticals Inc.'s opening brief addressing all of these appeals, and Mallinckrodt LLC's response brief addressing only issues associated with 17-1094, -1240, -1444, -1455, are due no later than 05/01/2017. Amneal Pharmaceuticals LLC et al.'s response/reply brief, addressing only issues associated with 17-1094, -1240, -1444, -1455, and Actavis LLC et al.'s response brief, addressing only issues associated with 17-1887, are due no later than 06/12/2017. Endo's reply brief is due no later than 06/26/2017. Service as of this date by Clerk of Court. [423414] [17-1094, 17-1240, 17-1444, 17-1455, 17-1887] [MJL] [Entered: 04/12/2017 11:52 AM] (2)
Apr 12, 2017 11 Note to file: The following cases are consolidated: 17-1094 (Lead) with 17-1240, -1444, -1455, -1887 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [423608] [17-1094, 17-1240, 17-1444, 17-1455, 17-1887] [MJL] [Entered: 04/12/2017 04:33 PM] (0)
Mar 10, 2017 9 Note to file: The following cases are associated:17-1094 Lead with 17-1240, 17-1444, 17-1455 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [414391] [17-1094, 17-1240, 17-1444, 17-1455] [JCA] [Entered: 03/10/2017 01:13 PM] (0)
Jan 18, 2017 3 Entry of appearance for Jeffrey J. Toney as principal counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399906] [Jeffrey Toney] [Entered: 01/18/2017 11:54 AM] (2)
Jan 18, 2017 4 Entry of appearance for Rodney R. Miller as of counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399915] [Rodney Miller] [Entered: 01/18/2017 11:57 AM] (2)
Jan 18, 2017 5 Entry of appearance for Paul G. Williams as of counsel for Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399920] [Paul Williams] [Entered: 01/18/2017 12:00 PM] (2)
Jan 18, 2017 6 Certificate of Interest for the Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399922] [Jeffrey Toney] [Entered: 01/18/2017 12:02 PM] (3)
Jan 18, 2017 7 Docketing Statement for the Appellee Mallinckrodt LLC. Service: 01/18/2017 by email. [399925] [Jeffrey Toney] [Entered: 01/18/2017 12:05 PM] (4)
Jan 18, 2017 8 CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellee's entries of appearance, certificate of interest, and docketing statement (Nos. [3], [4], [5], [6], & [7]) are filed in the consolidated cross-appeal docket. CORRECTION: Documents should be added to the lead appeal only. Refiling the listed documents is unnecessary, since they were also filed in the lead. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [399954] [CMP] [Entered: 01/18/2017 01:19 PM] (0)
Jan 6, 2017 1 Appeal docketed. Received: 01/05/2017. [396773] [MJL] [Entered: 01/06/2017 02:09 PM] (35)
Jan 6, 2017 2 Note to file: The following cases are consolidated: 17-1444 (Lead) with 17-1455 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [396776] [17-1444, 17-1455] [MJL] [Entered: 01/06/2017 02:14 PM] (0)
Menu